Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

An apple a day to keep inflammation away?


An apple a day to keep inflammation away?

Auckland, New Zealand. 10 December 2012…New research suggests that apples may be good for the millions of people worldwide suffering from inflammatory diseases.

Scientists at Plant & Food Research analysed the concentrations of 27 compounds thought to be beneficial to health in 109 different cultivars of apple - 94 from the Plant & Food Research germplasm collection and 15 grown in Luxembourg. From these, five cultivars were selected that represented the extremes of chemical profiles identified. Extracts of the flesh and skin from each of these cultivars were analysed in laboratory cell-based assays for the apples’ effect on key components of human inflammation.

The results showed that the apples with high levels of two families of compounds -the procyanidins and triterpenes - inhibited the activation of two molecules (NF-B and TNF) known to play a role in inflammation and are key in inflammatory diseases, such as Inflammatory Bowel Disease (IBD).

“Apple is one of the most highly consumed fruits worldwide,” says Dr William Laing, Science Group Leader Biological Chemistry and Bioactives at Plant & Food Research. “Understanding which compounds in apple influence pathways in disease, such as IBD, allows us to breed new varieties of apple with more of these compounds that can then be used as ingredients in foods specifically designed to control the disease symptoms.”

Scientists from Plant & Food Research worked in conjunction with a research team at the Centre de Recherche Public-Gabriel Lippmann in Luxembourg. The research was conducted as part of the Nutrigenomics New Zealand programme, a multidisciplinary research collaboration between Plant & Food Research, The University of Auckland and AgResearch, and funded by the Ministry of Business, Innovation and Employment. The programme aims to determine how food and food composition affects health based on genetic information. Ultimately, the programme intends to develop gene-specific foods that prevent, control or cure disease. The initial target for the programme is Crohn’s disease and other inflammatory bowel disorders. Approximately 15,000 people are affected by these disorders in New Zealand.

The research is published in the latest edition of the Journal of Agricultural and Food Chemistry.


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

By May 2018: Wider, Earlier Microbead Ban

The sale and manufacture of wash-off products containing plastic microbeads will be banned in New Zealand earlier than previously expected, Associate Environment Minister Scott Simpson announced today. More>>

ALSO:

Snail-ier Mail: NZ Post To Ditch FastPost

New Zealand Post customers will see a change to how they can send priority mail from 1 January 2018. The FastPost service will no longer be available from this date. More>>

ALSO:

Property Institute: English Backs Of Debt To Income Plan

Property Institute of New Zealand Chief Executive Ashley Church is applauding today’s decision, by Prime Minister Bill English, to take Debt-to-income ratios off the table as a tool available to the Reserve Bank. More>>

ALSO:

Divesting: NZ Super Fund Shifts Passive Equities To Low-Carbon

The NZ$35 billion NZ Super Fund’s NZ$14 billion global passive equity portfolio, 40% of the overall Fund, is now low-carbon, the Guardians of New Zealand Superannuation announced today. More>>

ALSO:

Split Decision - Appeal Planned: EPA Allows Taranaki Bight Seabed Mine

The Decision-making Committee, appointed by the Board of the Environmental Protection Authority to decide a marine consent application by Trans-Tasman Resources Ltd, has granted consent, subject to conditions, for the company to mine iron sands off the South Taranaki Bight. More>>

ALSO: